Recent advancements in our understanding of type 2 diabetes mellitus and atherosclerosis have highlighted the significant role of inflammation in their development. This realization opens up opportunities for novel therapeutic strategies to reduce the prevalence of these public health issues. TNF alpha[...]
Read MoreHybridoma technology is a technique that helps obtain monoclonal antibodies by combining a certain antibody that produces B cells with myeloma cells. Through the Hybridoma technology steps, the monoclonal antibodies are made. This method, which is regarded as being extremely reliable, can[...]
Read MoreHybridoma technology steps are a series of entrenched methods to produce mAbs (monoclonal antibodies) to antigens of interest. Hybridoma cell lines are formed by combining a short-lived antibody-producing B cell and an immortal myeloma cell. Every hybridoma constitutively conveys a considerable amount[…]
Read More